Literature DB >> 6281332

Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.

R J Ziccardi.   

Abstract

For biochemical characterization, the first component of human complement (C1) was reconstituted from physiologic concentrations of purified C1q, 125I C1r, and 131I C1s. Upon incubation at 37 degrees C, C1 spontaneously activated, as evidenced by the characteristic proteolysis of the C1r and C1s polypeptide chains as detected by SDS-PAGE analysis. This spontaneous C1 activation followed first-order kinetics (t 1/2 = 4 min and k = 0.173 min-1) with an activation energy of 19.1 kcal/mol. Spontaneous C1 activation was unaffected by the general protease inhibitor phenylmethylsulfonylfluoride (PMSF) but reversibly blocked by a known inhibitor of C1 activation, nitrophenylguanidinobenzoate (NPGB). Spontaneous C1 activation was measured at C1 concentrations ranging from 9 to 160 nM (i.e., 0.05 to 1.0 times physiologic concentrations). The data indicate that C1 spontaneously activates by an intramolecular autocatalytic mechanism, for first-order kinetics were observed over the entire concentration range with t 1/2 = 4 min at each concentration. However, the percentage of activable C1 decreased with dilution due to C1 dissociation (i.e., C1qr2s2 leads to C1q + C1r2s2). The observed concentration of C1 that spontaneously activated at each dilution equalled the concentration of C1 present as macromolecular C1. When reconstituted C1 was mixed with normal human serum (NHS) and then incubated at 37 degrees C, spontaneous C1 activation was completely inhibited. Pretreating NHS at 56 degrees C for 30 min destroyed its inhibitory activity. In conclusion, C1 spontaneously autoactivates at 37 degrees C by an intramolecular mechanism. This activation is suppressed in NHS.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281332

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Production of multidomain complement glycoproteins in insect cells.

Authors:  P Závodzky; S Cseh
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

Review 2.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

3.  Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex.

Authors:  Sébastien Brier; Delphine Pflieger; Maxime Le Mignon; Isabelle Bally; Christine Gaboriaud; Gérard J Arlaud; Régis Daniel
Journal:  J Biol Chem       Date:  2010-06-30       Impact factor: 5.157

Review 4.  Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.

Authors:  Allen P Kaplan; Kusumam Joseph
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

5.  Structure and activation of C1, the complex initiating the classical pathway of the complement cascade.

Authors:  Simon A Mortensen; Bjoern Sander; Rasmus K Jensen; Jan Skov Pedersen; Monika M Golas; Jens C Jensenius; Annette G Hansen; Steffen Thiel; Gregers R Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-19       Impact factor: 11.205

6.  The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex.

Authors:  Monika Budayova-Spano; Monique Lacroix; Nicole M Thielens; Gérard J Arlaud; Juan Carlos Fontecilla-Camps; Christine Gaboriaud
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

7.  Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen.

Authors:  J E Schweinle; P J Hitchcock; A J Tenner; C H Hammer; M M Frank; K A Joiner
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

8.  Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation.

Authors:  T E Mollnes; P Garred; G Bergseth
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

9.  Eosinophil granule cationic proteins regulate the classical pathway of complement.

Authors:  J M Weiler; R E Edens; C S Bell; G J Gleich
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

10.  The role of C1, C1-inactivator and C4 in modulating immune precipitation.

Authors:  J A Schifferli; G Steiger; M Schapira
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.